RAPPORT THERAPEUTICS INC (RAPP) — insider trading
Health Care · NASDAQ
RAPPORT THERAPEUTICS INC (RAPP) has 43 reported SEC Form 4 insider transactions in our data, including 35 open-market sales among the most recent 43 (latest 2026-10-07).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-07 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 1,147 | $30.66 | $35.2K | Form 4 |
| 2026-10-06 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 3,375 | $32.03 | $108.1K | Form 4 |
| 2026-09-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 2,075 | $33.76 | $70.0K | Form 4 |
| 2026-09-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 7,925 | $33.04 | $261.8K | Form 4 |
| 2026-09-23 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 43 | $41.05 | $1.8K | Form 4 |
| 2026-09-23 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 215 | $39.86 | $8.6K | Form 4 |
| 2026-09-23 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 1,952 | $39.05 | $76.2K | Form 4 |
| 2026-09-08 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 1,069 | $46.01 | $49.2K | Form 4 |
| 2026-09-08 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 7,141 | $45.56 | $325.3K | Form 4 |
| 2026-08-25 | Yeleswaram Krishnaswamy | Officer (Chief Development Officer) | Open-market sale | 16,201 | $51.06 | $827.2K | Form 4 |
| 2026-08-25 | Yeleswaram Krishnaswamy | Officer (Chief Development Officer) | Open-market sale | 20,799 | $50.31 | $1.05M | Form 4 |
| 2026-08-25 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 18,921 | $49.57 | $938.0K | Form 4 |
| 2026-08-24 | Yeleswaram Krishnaswamy | Officer (Chief Development Officer) | Open-market sale | 13,160 | $50.00 | $658.0K | Form 4 |
| 2026-08-19 | Yeleswaram Krishnaswamy | Officer (Chief Development Officer) | Open-market sale | 404 | $49.90 | $20.2K | Form 4 |
| 2026-08-11 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 5,794 | $48.62 | $281.7K | Form 4 |
| 2026-08-11 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 19,500 | $48.04 | $936.8K | Form 4 |
| 2026-08-11 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 3,664 | $46.90 | $171.8K | Form 4 |
| 2026-08-10 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 8,370 | $46.75 | $391.3K | Form 4 |
| 2026-08-10 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 14,171 | $45.97 | $651.5K | Form 4 |
| 2026-07-27 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 7 | $42.74 | $299 | Form 4 |
| 2026-07-27 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 2,203 | $42.11 | $92.8K | Form 4 |
| 2026-07-14 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 2,729 | $40.57 | $110.7K | Form 4 |
| 2026-07-14 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 5,481 | $39.72 | $217.7K | Form 4 |
| 2026-06-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 1,000 | $43.15 | $43.2K | Form 4 |
| 2026-06-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 3,308 | $42.17 | $139.5K | Form 4 |
| 2026-06-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 3,792 | $41.39 | $157.0K | Form 4 |
| 2026-06-30 | Gault Cheryl | Officer (Chief Operating Officer) | Open-market sale | 1,900 | $40.09 | $76.2K | Form 4 |
| 2026-06-29 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 876 | $40.34 | $35.3K | Form 4 |
| 2026-06-29 | Ceesay Abraham | Director, Officer (Chief Executive Officer) | Open-market sale | 7,344 | $39.77 | $292.1K | Form 4 |
| 2026-06-10 | Sanchez Ramiro | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | Young Wendy B. | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | Huber Reid M | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | HEALY JAMES | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | Silva Paul M | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | PAUL STEVEN M | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | PEREZ ROBERT J | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-06-10 | MARAGANORE JOHN | Director | Grant / award / vesting (derivative) | 15,200 | — | $0 | Form 4 |
| 2026-05-26 | Third Rock Ventures V, L.P.; Third Rock Ventures GP V, LP; TRV GP V, LLC; Third Rock Ventures VI, L.P.; Third Rock Ventures GP VI, L.P.; TRV GP VI, LLC | 10% owner | Open-market sale | 18,572 | $40.05 | $743.8K | Form 4 |
| 2026-05-11 | Third Rock Ventures V, L.P.; Third Rock Ventures GP V, LP; TRV GP V, LLC; Third Rock Ventures VI, L.P.; Third Rock Ventures GP VI, L.P.; TRV GP VI, LLC | 10% owner | Open-market sale | 133,618 | $40.24 | $5.38M | Form 4 |
| 2026-05-08 | Third Rock Ventures V, L.P.; Third Rock Ventures GP V, LP; TRV GP V, LLC; Third Rock Ventures VI, L.P.; Third Rock Ventures GP VI, L.P.; TRV GP VI, LLC | 10% owner | Open-market sale | 5,018 | $40.31 | $202.3K | Form 4 |
| 2026-05-07 | Third Rock Ventures V, L.P.; Third Rock Ventures GP V, LP; TRV GP V, LLC; Third Rock Ventures VI, L.P.; Third Rock Ventures GP VI, L.P.; TRV GP VI, LLC | 10% owner | Open-market sale | 271,495 | $40.12 | $10.89M | Form 4 |
| 2026-04-17 | Yeleswaram Krishnaswamy | Officer (Chief Development Officer) | Open-market sale | 20,225 | $39.99 | $808.8K | Form 4 |
| 2026-04-17 | Third Rock Ventures V, L.P.; Third Rock Ventures GP V, LP; TRV GP V, LLC; Third Rock Ventures VI, L.P.; Third Rock Ventures GP VI, L.P.; TRV GP VI, LLC | 10% owner | Open-market sale | 426,005 | $40.32 | $17.18M | Form 4 |
Ask the chat about RAPP's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: RAPPORT THERAPEUTICS INC (RAPP).
Last updated 2026-10-07 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.